2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals

Eurosurveillance

Volumn 20, Issue 2, 2015, Pages

  Rondy, M ^a   Launay, O ^b,c,d   Puig Barbera J ^e   Gefenaite, G ^f,g   Castilla, J ^h,i   de Gaetano Donati, K ^j   Galtier, F ^b,d,k   Hak, E ^f,g   Guevara, M ^h,i   Costanzo, S ^l   Moren, A ^a   Lenzi, Nezha ^m   Lesieur, Zineb ^m   Bonmarin, Isabelle ⁿ   Duval, Xavier ^o   Costa, Yolande ^o   Kanagaratnam, Annuxcy ^o   Yazdapanah, Yazdan ^o   Caseris, Marion ^o   Dournon, Nathalie ^o   Papo, Thomas ^o   Dossier, Antoine ^o   Bécheur, Hakim ^o   Pelletier, Anne Laure ^o   Mal, Hervé ^o   Marceau, Armelle ^o   Aubier, Michel ^o   Bories, Raphaêl ^o   Casalino, Enrique ^o   Choquet, Christophe ^o   Houhou, Nadhira ^o   Loulergue, Pierre ^c   Kanaan, Reem ^c   Dumas, Florence ^c   Postil, Déborah ^p   Alcoléa, Sébastien ^p   Rogez, Sylvie ^p   Vanhaems, Philippe ^q   Régis, Corinne ^q   Merle, Corinne ^k   Foulongne, Vincent ^k   Ray, Marine ^k   Maugueret Doublet, Véronique ^k   Bourdin, Arnaud ^k   Landreau, Liliane ^k   Konaté, Amadou ^k   Corne, Philippe ^k   Sebbane, Mustapha ^k   Klouche, Kada ^k   Léglise, Marie Suzanne ^k   Valette, Martine ^r   Lina, Bruno ^r   Carrat, Fabrice ^d   Chau, Frédéric ^d   Díez Domingo, Javier ^s   Escribano López, Begoña ^s   Arnedo Pena, Alberto ^t   Ruiz García, Montserrat ^t   Tortajada Girbés, Miguel ^u   Munuera, Consuelo Carratalá ^v   Sañudo, Julio Barrenengoa ^w   Larrea González, Rosa ^w   Gil Guillén, Vicente ^x   Schwarz Chavarri, German ^y   Rahamat Langendoen, Janette ^f   Niesters, Hubert ^f   Ambrozaitis, Arvydas ^z   Jancoriene, Ligita ^z   Mickiene, Aukse ^aa   Kuliese, Monika ^aa   Velyvyte, Daiva ^aa   Stolk, Ronald P ^g   Zagminas, Kestutis ^z   Ezpeleta, Carmen ^ab   Chamorro, Judith ^ab   Artajo, Pilar ^ab   Lameiro, Francisco ^ac   Navascués, Ana ^ac   Ortega, Maite ^ad   Torres, Montse ^ad   Irure, José Javier García ^ad   Irisarri, Fátima ^h   Cenoz, Manuel García ^h   Martínez Baz, Iván ^h   Cauda, Roberto ^ae   Donato, Concetta ^ae   Santangelo, Rosaria ^ae   Perlasca, Francesco ^af   Fichera, Giovanni ^af   Dara, Marianna ^af   Iacoviello, Licia ^l   Olivieri, Marco ^ag   more..

^a EPICONCEPT   (France)

^b French Clinical Vaccinology Network (REIVAC)   (France)

^c Cochin hospital ^*  (France)

^d INSERM   (France)

^e Area of Vaccines Research   (Spain)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j CATHOLIC UNIVERSITY   (Italy)

^k HÔPITAL SAINT ELOI   (France)

^l IRCCS NEUROMED   (Italy)

^m The French Clinical Vaccinology Network Réseau National d'Investigation Clinique en Vaccinologie REIVAC   (France)

ⁿ INSTITUT DE VEILLE SANITAIRE   (France)

^o BICHAT HOSPITAL   (France)

^p DUPUYTREN UNIVERSITY HOSPITAL   (France)

^q UNIVERSITÉ LYON 1   (France)

^r UNIVERSITÉ DE LYON   (France)

^s Valencia Hospital Network: FISABIO   (Spain)

^t HOSPITAL DE LA PLANA   (Spain)

^u HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^v MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^w HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^x Hospital de Elda   (Spain)

^y Centro de Salud San Blas   (Spain)

^z VILNIUS UNIVERSITY   (Lithuania)

^aa LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^ab Universidad Pública de Navarra   (Spain)

^ac HOSPITAL GARCÍA ORCOYEN   (Spain)

^ad Anatomía Patológica del Hospital Reina Sofía de Tudela   (Bulgaria)

^ae FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^af OSPEDALE DI CIRCOLO   (Italy)

^ag SRL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; EUROPE; EUROPEAN UNION; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; SEASON; SENTINEL SURVEILLANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VACCINATION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPE; EUROPEAN UNION; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; SEASONS; SENTINEL SURVEILLANCE; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 84926507200     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.2.21011     Document Type: Article

References (38)

1. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007; 25(39-40): 6852-62. Available from: http: //dx.doi.org/10.1016/j.vaccine.2007.07.027 PMID: 17719149
2. Influenza vaccines. Wkly Epidemiol Rec. 2005; 80(33): 279-87. Available from: PMID: 16171031
3. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines. London: European Medicines Agency; Mar 1997. CPMP/BWP/214/96. Available from: http: //www. ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2009/09/WC500003945.pdf
4. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol. 2010; 10(1): 18. Available from: http: //dx.doi. org/10.1186/1471-2288-10-18 PMID: 20210985
5. McCullers JA, Huber VC. Correlates of vaccine protection from influenza and its complications. Hum Vaccin Immunother. 2012; 8(1): 34-44. Available from: http: //dx.doi.org/10.4161/ hv.8.1.18214 PMID: 22252001
6. World Health Organiation (WHO) Strategic Advisory Group of Experts on immunization (SAGE). Background paper on influenza vaccines and immunization. SAGE Working Group. Geneva: WHO; 2012. [Accessed 19 Apr 2013]. Available from: http: //www.who.int/immunization/sage/meetings/2012/ april/1_Background_Paper_Mar26_v13_cleaned.pdf
7. Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, et al. VENICE project gatekeepers group. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill. 2010; 15(44): 19700. Available from: PMID: 21087586
8. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. February 2012. Geneva: WHO; 2012. Available from: http: //www.who.int/influenza/vaccines/ virus/recommendations/201202_recommendation.pdf
9. Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013; 56(10): 1363-9. Available from: http: //dx.doi.org/10.1093/ cid/cit060 PMID: 23413420
10. Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014; 58(3): 319-27. doi: 10.1093/cid/cit736 PMID: 24235265
11. McLean H, Sundaram M, Kieke B, Meece J, McClure D, Thompson M, et al. Current and previous season vaccination have similar effectiveness for preventing medically attended influenza A (H3N2) and B: results from a community cohort over 8 seasons. Poster presentation at Options for the control of Influenza VIII, Cape Town, South Africa, 5-10 Sep 2013.
12. Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. PLoS ONE. 2013; 8(4): e59681. Available from: http: //dx.doi. org/10.1371/journal.pone.0059681 PMID: 23565159
13. European Centre for Disease Prevention and Control (ECDC). Influenza virus characterisation. Summary Europe, July 2012. Stockholm: ECDC; 2013. Available from: http: //ecdc.europa.eu/ en/publications/Publications/influenza-virus-characterisation-July-2013.pdf.
14. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010; 28(46): 7381-8. Available from: http: //dx.doi. org/10.1016/j.vaccine.2010.09.010 PMID: 20851086
15. Seyler T, Rondy M, Valenciano M, Moren A. Protocol for hospital-based case control studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza hospitalisations across the European Union and European Economic Area Member States. May 2014. I-MOVE. Available from: https: //drive.google.com/viewerng/ viewer?a=v&pid=sites& srcid=ZGVmYXVsdGRvbWFpbnxlcGlmb HV8Z3g6NGY3ZGYyZDQ1OGQ3OGIxOA
16. Haut Conseil de la Santé Publique. Le Calendrier des vaccinations et les recommandations vaccinales 2012 selon l'avis du Haut Conseil de la sante publique. [2012 vaccination schedule and recommendations from the Haut conseil de la sante publique in France]. Bulletin epidemiologique hebdomadaire. 2012; 14-15: 163-87. French. Available from: http: //www.sante.gouv.fr/IMG/pdf/beh_14_15_1_.pdf.
17. Ministero della Salute. Prevenzione e controllo dell'influenza: raccomandazioni per la stagione 2012-2013. [Prevention and control of influenza: recommendations for the season 2012-2013]. Roma: Ministero della Salute; 2012. Italian. Available from: http: //www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?l ingua=italiano&menu=notizie&p=dalministero&id=463
18. Vaccine European New Integrated Collaboration Effort (VENICE) II Consortium. Seasonal influenza vaccination survey in EU/ EEA, influenza season 2009-10. Final report. VENICE; 2011. Available from: http: //venice.cineca.org/Final_Seasonal_ Influenza_Vaccination_Survey_2010.pdf
19. Instituto de Salud Publica de Navarra. Protocolo de vacunacion antigripal 2012-2013, [2012-13 Influenza vaccination protocol]. Boletin informative. 2012; 69: 1-4. Spanish. Available from: http: //www.navarra.es/NR/rdonlyres/AECCD760-AB2A-4841-818A-FA53478FD6DC/233865/BOL69INT2012_2013.pdf
20. Vacunacion antigripal estacional 2012. [Influenza vaccination, 2012 season]. Direccio General d'Investigacio i Salut Publica, Generalitat Vaclenciana. Spanish.
21. International Organization for Standardization (ISO). ISO 8601: 2004: Data elements and interchange formats--Information interchange--Representation of dates and times. Geneva: ISO; 2004.
22. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965; 14: 61-5. Available from: PMID: 14258950
23. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006; 11(2): 193-206. Available from: http: //dx.doi.org/10.1037/1082-989X.11.2.193 PMID: 16784338
24. Stukel TA, Demidenko E, Dykes J, Karagas MR. Twostage methods for the analysis of pooled data. Stat Med. 2001; 20(14): 2115-30.
25. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer; 2001.
26. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case testnegative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013; 31(30): 3104-9. Available from: http: // dx.doi.org/10.1016/j.vaccine.2013.04.026 PMID: 23624093
27. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013; 31(17): 2165-8. Available from: http: //dx.doi.org/10.1016/j. vaccine.2013.02.053 PMID: 23499601
28. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007; 36(3): 623-31. Available from: http: //dx.doi.org/10.1093/ije/dym021 PMID: 17403908
29. Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis. 2006; 194(s2) Suppl 2; S98-110. Available from: http: //dx.doi.org/10.1086/507554 PMID: 17163396
30. World Health Organization (WHO) Regional Office for Europe. In-patient care discharges per 100. European Health for All database (HFA-DB). Copenhagen: WHO Regional Office for Europe. [Accessed 28 Dec 2014]. Available from: http: // www.euro.who.int/en/data-and-evidence/databases/ european-health-for-all-database-hfa-db
31. Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013; 56(10): 1363-9. Available from: http: //dx.doi.org/10.1093/ cid/cit060 PMID: 23413420
32. Davies JR, Grilli EA. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect. 1989; 102(2): 325-33 http: //dx.doi.org/10.1017/ S0950268800030004 PMID: 2703026
33. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA. 1999; 96(24): 14001-6. Available from: http: //dx.doi. org/10.1073/pnas.96.24.14001 PMID: 10570188
34. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS ONE. 2011; 6(7): e21690. Available from: http: //dx.doi. org/10.1371/journal.pone.0021690 PMID: 21747947
35. Sasaki S, He X-S, Holmes TH, Dekker CL, Kemble GW, Arvin AM, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE. 2008; 3(8): e2975. Available from: http: //dx.doi.org/10.1371/journal.pone.0002975 PMID: 18714352
36. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre casecontrol study. Euro Surveill. 2013; 18(5): 20390. Available from: PMID: 23399425
37. Pebody R, Andrews N, McMenamin J, Durnall H, Ellis J, Thompson CI, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill. 2013; 18(5): 20389. Available from: PMID: 23399424
38. Castilla J, Martinez-Baz I, Martinez-Artola V, Reina G, Pozo F, Garcia Cenoz M, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill. 2013; 18(5): 20388. Available from: PMID: 23399423